doi:10.3109/10837450.2014.979944 Evidence-Base Disclosure The published evidence base for GHK-Cu consists predominantly of preclinical research animal models (often rats or mice) and in vitro cell-culture experiments
For a patient to truly consent to a treatment, they need to understand its risks, benefits, and alternatives
Amylin is a natural hormone released from beta cells in the pancreas, of course, GLP-1 from the GI tract
However, measuring cytotoxicity alone is not sufficient
And in extreme cases, theres the risk of delaying necessary, vetted help
Functional medicine providers may use peptide therapy for leaky gut (intestinal hyperpermeability), IBS, IBD-related symptoms, gastritis or ulcer recovery, post-antibiotic dysbiosis, and chronic GI inflammation